dihydrocodeine tartrate · Medicine question

By which route is the Ennogen IP Ltd dihydrocodeine tartrate 90 mg prolonged-release tablet product administered?

Name: By which route is the Ennogen IP Ltd dihydrocodeine tartrate 90 mg prolonged-release tablet product administered?
Published: 2026-11-08T13:50:53.172Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

The Ennogen IP Ltd dihydrocodeine tartrate 90 mg prolonged-release tablet product is administered orally.

Sources for this answer

Dihydrocodeine 90 mg prolonged release tabletsEnnogen IP Ltd · emc · SmPC §4.2 Posology and method of administration · Version 4Document updated 28 February 2025

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about dihydrocodeine tartrate